$168 Million is the total value of Birchview Capital, LP's 54 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $50,137,000 | +1.7% | 794,186 | -0.0% | 29.76% | +4.8% |
| BDSX | Sell | BIODESIX INC | $22,442,000 | +0.7% | 1,104,953 | -0.0% | 13.32% | +3.8% |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $18,386,000 | +10.6% | 2,213,326 | +0.9% | 10.92% | +13.9% |
| NBIX | NEUROCRINE BIOSCIENCES INC | $7,799,000 | +1.5% | 80,200 | 0.0% | 4.63% | +4.5% | |
| QDEL | QUIDEL CORP | $7,502,000 | -28.8% | 58,644 | 0.0% | 4.45% | -26.6% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $4,567,000 | -16.2% | 177,000 | +73.5% | 2.71% | -13.7% |
| FHTX | FOGHORN THERAPEUTICS INC | $4,140,000 | -35.0% | 314,143 | 0.0% | 2.46% | -33.0% | |
| ALBO | Buy | ALBIREO PHARMA INC | $3,913,000 | +13.4% | 111,000 | +20.7% | 2.32% | +16.9% |
| BIIB | BIOGEN INC | $3,385,000 | +14.2% | 12,100 | 0.0% | 2.01% | +17.8% | |
| UTHR | UNITED THERAPEUTICS CORP | $3,011,000 | +10.2% | 18,000 | 0.0% | 1.79% | +13.6% | |
| XLRN | ACCELERON PHARMA INC | $2,532,000 | +6.0% | 18,672 | 0.0% | 1.50% | +9.2% | |
| CGEM | New | CULLINAN ONCOLOGY INC | $2,505,000 | – | 60,114 | +100.0% | 1.49% | – |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $2,420,000 | -16.8% | 230,000 | +22.3% | 1.44% | -14.3% |
| BLUE | Buy | BLUEBIRD BIO INC | $2,276,000 | -15.2% | 75,500 | +21.8% | 1.35% | -12.6% |
| AMRN | AMARIN CORP PLCspons adr new | $1,863,000 | +27.0% | 300,000 | 0.0% | 1.11% | +30.9% | |
| NKTR | New | NEKTAR THERAPEUTICS | $1,840,000 | – | 92,000 | +100.0% | 1.09% | – |
| MASI | MASIMO CORP | $1,837,000 | -14.4% | 8,000 | 0.0% | 1.09% | -11.8% | |
| IMGN | IMMUNOGEN INC | $1,539,000 | +25.5% | 190,000 | 0.0% | 0.91% | +29.5% | |
| CCXI | CHEMOCENTRYX INC | $1,537,000 | -17.3% | 30,000 | 0.0% | 0.91% | -14.8% | |
| ARNA | ARENA PHARMACEUTICALS INC | $1,527,000 | -9.6% | 22,000 | 0.0% | 0.91% | -6.9% | |
| PROG | Buy | PROGENITY INC | $1,285,000 | -3.2% | 270,000 | +8.0% | 0.76% | -0.3% |
| HROW | HARROW HEALTH INC | $1,215,000 | -1.6% | 180,000 | 0.0% | 0.72% | +1.4% | |
| VNDA | VANDA PHARMACEUTICALS INC | $1,202,000 | +14.4% | 80,000 | 0.0% | 0.71% | +18.0% | |
| CORT | CORCEPT THERAPEUTICS INC | $1,190,000 | -9.0% | 50,000 | 0.0% | 0.71% | -6.4% | |
| SLNO | Buy | SOLENO THERAPEUTICS INC | $1,105,000 | -30.8% | 876,899 | +6.0% | 0.66% | -28.6% |
| ANGN | New | ANGION BIOMEDICA CORP | $1,095,000 | – | 60,615 | +100.0% | 0.65% | – |
| ETRN | EQUITRANS MIDSTREAM CORPORATIO | $1,086,000 | +1.5% | 133,050 | 0.0% | 0.64% | +4.7% | |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $1,028,000 | +80.4% | 40,000 | +33.3% | 0.61% | +86.0% |
| CLR | CONTINENTAL RESOURCES INC | $999,000 | +58.8% | 38,600 | 0.0% | 0.59% | +63.8% | |
| ARVN | ARVINAS INC | $992,000 | -22.1% | 15,000 | 0.0% | 0.59% | -19.8% | |
| GTHX | G1 THERAPEUTICS INC | $962,000 | +33.6% | 40,000 | 0.0% | 0.57% | +37.6% | |
| CFRX | CONTRAFECT CORP | $960,000 | -5.0% | 200,000 | 0.0% | 0.57% | -2.1% | |
| OVV | OVINTIV INC | $818,000 | +65.9% | 34,350 | 0.0% | 0.49% | +71.1% | |
| NARI | INARI MEDICAL INC | $749,000 | +22.6% | 7,000 | 0.0% | 0.44% | +26.4% | |
| TGTX | TG THERAPEUTICS INC | $723,000 | -7.3% | 15,000 | 0.0% | 0.43% | -4.5% | |
| AWH | Sell | ASPIRA WOMENS HEALTH INC | $696,000 | -87.6% | 103,104 | -87.7% | 0.41% | -87.2% |
| BHVN | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $684,000 | -20.2% | 10,000 | 0.0% | 0.41% | -17.8% | |
| PGNY | PROGYNY INC | $668,000 | +5.0% | 15,000 | 0.0% | 0.40% | +8.5% | |
| ALKS | New | ALKERMES PLC | $654,000 | – | 35,000 | +100.0% | 0.39% | – |
| PXD | PIONEER NATURAL RESOURCES CO | $604,000 | +39.5% | 3,800 | 0.0% | 0.36% | +44.2% | |
| STOK | Sell | STOKE THERAPEUTICS INC | $583,000 | -52.9% | 15,000 | -25.0% | 0.35% | -51.5% |
| XNCR | XENCOR INC | $530,000 | -1.3% | 12,300 | 0.0% | 0.32% | +1.9% | |
| LSF | New | LAIRD SUPERFOOD INC | $525,000 | – | 14,000 | +100.0% | 0.31% | – |
| TBIO | TRANSLATE BIO INC | $495,000 | -10.5% | 30,000 | 0.0% | 0.29% | -7.8% | |
| FOLD | AMICUS THERAPEUTICS INC | $375,000 | -57.2% | 38,000 | 0.0% | 0.22% | -55.8% | |
| APLS | APELLIS PHARMACEUTICALS INC | $343,000 | -25.1% | 8,000 | 0.0% | 0.20% | -22.7% | |
| IFRX | INFLARX NV | $273,000 | -22.4% | 70,000 | 0.0% | 0.16% | -20.2% | |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $259,000 | – | 10,000 | +100.0% | 0.15% | – |
| ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $260,000 | – | 9,000 | +100.0% | 0.15% | – |
| DRNA | DICERNA PHARMACEUTICALS INC | $256,000 | +16.4% | 10,000 | 0.0% | 0.15% | +19.7% | |
| YTEN | YIELD10 BIOSCIENCE INC | $238,000 | +116.4% | 18,952 | 0.0% | 0.14% | +123.8% | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $203,000 | +36.2% | 20,000 | 0.0% | 0.12% | +40.7% | |
| TXMD | New | THERAPEUTICSMD INC | $134,000 | – | 100,000 | +100.0% | 0.08% | – |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $100,000 | – | 20,000 | +100.0% | 0.06% | – |
| ODT | Exit | ODONATE THERAPEUTICS INC | $0 | – | -20,000 | -100.0% | -0.22% | – |
| BMYRT | Exit | BMY CVR RTS 03/31/21right | $0 | – | -1,105,313 | -100.0% | -0.44% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -170,303 | -100.0% | -1.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.